Ouch! Needle-Phobic People Scarred by So Many Images of Covid Shots
The pictures are on the nightly news, on billboards, bus stop posters and all over social media. How can people who fear needles manage to get their covid shots?
FDA
281 - 300 of 472 Results
-
-
Why AstraZeneca and J&J鈥檚 Vaccines, In Use Elsewhere, Are Still on Hold in America
Covid has pressed the Food and Drug Administration into its fastest vaccine reviews ever 鈥 which are still painfully slow, critics say.
-
Have a Case of a Covid Variant? No One Is Going to Tell You
As experts race to get an approved test for covid variants, officials are severely restricted from sharing information about the cases. That makes it harder to protect others.
-
KHN鈥檚 鈥榃hat the Health?鈥: All About Budget Reconciliation
Even while the Senate is busy with Donald Trump鈥檚 impeachment trial, the House has gotten down to work on a covid relief bill using the budget reconciliation process. Meanwhile, the watchword for covid this week among the public is confusion 鈥 over masks, vaccines and just about everything else science-related. Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Sarah Karlin-Smith of the Pink Sheet join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, the panelists recommend their favorite 鈥渉ealth policy valentines鈥 along with their favorite health policy stories they think you should read, too.
-
Remdesivir, Given to Half of Hospitalized Covid Patients in U.S., Is Big Win for Gilead 鈥 Boosted by Taxpayers
With U.S. cases skyrocketing, demand for Gilead鈥檚 dark horse antiviral is only growing. Biden appointees propose potential legal tactics to tamp down the price for patients.
-
COVID Vaccines Appear Safe and Effective, but Key Questions Remain
The federal government expects vaccinations to be available to everyone who wants them by summer 鈥 though glitches are inevitable. If enough of us get vaccinated, we could wave goodbye to the pandemic in 2021.
-
Inside the First Chaotic Days of the Effort to Vaccinate America
After missteps in Washington, each state and county is left to juggle where to send vaccines first and how to get them to each nursing home, hospital local health department and even school.
-
Hospitals Scramble to Prioritize Which Workers Are First for COVID Shots
Even as the federal Food and Drug Administration engaged in intense deliberations ahead of Friday's authorization of the nation鈥檚 first COVID vaccine, and days before the initial doses were to be released, hospitals have been grappling with how to distribute the first scarce shots. Their plans vary broadly.
-
Demand for COVID Vaccines Expected to Get Heated 鈥 And Fast
With two vaccines against coronavirus disease poised for release within weeks, experts say they expect attitudes to shift dramatically from hesitancy to 鈥淏eanie Baby鈥-level urgency.
-
Come for Your Eye Exam, Leave With a Band-Aid on Your Arm
Dentists and optometrists across the country are trying to join in the fight to get everyone vaccinated against COVID-19, the flu and other diseases.
By Rachel Bluth -
KHN on the Air This Week
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here鈥檚 a collection of their appearances.
-
As Nation Awaits Vaccine, Biden Is Under Pressure to Name New FDA Chief ASAP
It typically takes months to install new leadership, but with COVID deaths set to surge through the winter, many Democrats say Biden doesn鈥檛 have that sort of time.
-
Distrusting Trump, States Plan to Vet COVID Vaccines Themselves. Bad Idea, Say Experts.
California and at least five other states have said they may independently vet any vaccines. Experts warn that could needlessly confuse the public.
By JoNel Aleccia and Liz Szabo -
Easier-to-Use Coronavirus Saliva Tests Start to Catch On
Regulators and scientists have been leery of introducing the tests, preferring to rely on tried-and-true methods, but evidence is mounting that the spit and swab tests may be more convenient and just as accurate.
By David Tuller -
These Secret Safety Panels Will Pick the COVID Vaccine Winners
Data and safety monitoring boards work under a cloak of secrecy meant to prevent undue influence by stakeholders, such as companies or the government. In the Trump era, some worry the anonymity could actually invite it.
-
Election Gift for Florida? Trump Poised to Approve Drug Imports From Canada
The Trump administration is primed to approve a plan designed to help lower costs of some prescription drugs by allowing states to import them from Canada. The announcement could come before Election Day, and Florida appears to be in line to go first.
-
KHN鈥檚 鈥榃hat the Health?鈥: It鈥檚 Scandal Week
President Donald Trump this week issued a prescription drug pricing order unlikely to lower drug prices, and he contradicted comments by his director of the Centers for Disease Control and Prevention on the need for mask-wearing and predictions for vaccine availability. Meanwhile, scandals erupted at the CDC, the Centers for Medicare & Medicaid Services and the Food and Drug Administration. And the number of people without health insurance grew in 2019, reported the Census Bureau, even while the economy soared. Alice Miranda Ollstein of Politico, Tami Luhby of CNN and Sarah Karlin-Smith of the Pink Sheet join KHN鈥檚 Julie Rovner to discuss this and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
-
KHN鈥檚 鈥榃hat the Health?鈥: The Politics of Science
Republicans have all but abandoned the Affordable Care Act as a campaign cudgel, judging from their national convention, at least. Meanwhile, career scientists at the federal government鈥檚 preeminent health agencies 鈥 the Food and Drug Administration, the Centers for Disease Control and Prevention and the National Institutes of Health 鈥 are all coming under increasing political pressure as the pandemic drags on. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHN鈥檚 Julie Rovner to discuss this and more. Plus, Rovner interviews KHN鈥檚 Elizabeth Lawrence about the latest KHN-NPR 鈥淏ill of the Month鈥 installment.
-
Most Adults Wary of Taking Any Vaccine Approved Before the Election
About 60% of poll respondents are worried that federal regulators will rush to allow a vaccine because of political pressure. Opposition to getting a vaccine that might be authorized before the November election is strongest among Republicans.
By Jordan Rau -
Dozens of U.S. Hospitals Poised to Defy FDA鈥檚 Directive on COVID Plasma
The FDA, under pressure from the Trump administration, has authorized broader use of convalescent plasma for emergency treatment in COVID patients. But several major hospitals are resisting, saying they鈥檒l opt instead to use the scarce resource to complete a clinical trial.